OL
WST icon

Optas LLC’s West Pharmaceutical WST Stock Holding History

Optas LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+560
New +$171K 0.03% 461

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return

Optas LLC's WST Position: Q2 2026 in Review

Optas LLC opened a new position in West Pharmaceutical (WST) in Q2 2026: 560 shares worth $201K. The stake represents 0.03% of the portfolio and ranks #461 among its holdings.

167 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Optas LLC held 560 shares of West Pharmaceutical worth $201K as of Q2 2026.
  • West Pharmaceutical was a new Optas LLC position in Q2 2026.
  • West Pharmaceutical made up 0.03% of Optas LLC's portfolio in Q2 2026, its #461 holding.
  • 167 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.